Helpful Insights forPatients and Caregivers

Key Reminder

TD is a serious side effect that can be caused by long-term use of certain medications used to treat mental illness. While these medications are often necessary to treat mental illness, it is important that patients, family, and caregivers are aware of the signs and symptoms of TD so that it can be monitored and treated early.

References

  1. Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist. 2003;9(1):16-27. DOI: 10.1097/01.nrl.0000038585.58012.97. PubMed PMID: 12801428.
  2. Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor Other Hyperkinet Mov (N Y). 2013;3
  3. Jeste DV, Wyatt RJ. Changing epidemiology of tardive dyskinesia: an overview. Am J Psychiatry. 1981;138(3):297-309. DOI: 10.1176/ajp.138.3.297. PubMed PMID: 6110344.
  4. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord. 2006;21(5):589-98. DOI: 10.1002/mds.20823. PubMed PMID: 16532448.
  5. Munetz MR, Benjamin S. How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Community Psychiatry. 1988;39(11):1172-7. PubMed PMID: 2906320.
  6. Tarsy D, Baldessarini RJ. Tardive dyskinesia. Annu Rev Med. 1984;35:605-23. DOI: 10.1146/annurev.me.35.020184.003133. PubMed PMID: 6144288.
  7. Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, et al. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia. AJP. 2017;174(5):476-484. DOI: 10.1176/appi.ajp.2017.16091037. PubMed PMID: 28320223.
  8. Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, et al.. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry. 2017;4(8):595- 604. DOI: 10.1016/S2215-0366(17)30236-5.
  9. Lerner PP, Miodownik C, Lerner V. Tardive dyskinesia (syndrome): Current concept and modern approaches to its management. Psychiatry Clin Neurosci. 2015;69(6):321-34. DOI: 10.1111/pcn.12270. PubMed PMID: 25556809.